Sector ratings ResMed, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 17:29:26 21/04/2026 BST			5-day change	1st Jan Change
223.00 ^USD	-1.39%		-3.22%	-7.31%

04-15	Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating	MT
04-13	Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
RESMED, INC.	32.8B		A
THERMO FISHER SCIENTIFIC, INC.	195B		BBB
INTUITIVE SURGICAL, INC.	165B		BBB
DANAHER CORPORATION	138B		A
BOSTON SCIENTIFIC CORPORATION	90.64B		BBB
SIEMENS HEALTHINEERS AG	50.34B		BBB
EDWARDS LIFESCIENCES CORPORATION	46.95B		AAA
AGILENT TECHNOLOGIES, INC.	34.18B		AA
GE HEALTHCARE TECHNOLOGIES INC.	33.83B		A
WATERS CORPORATION	32.95B		AAA
PHILIPS NV	27.82B		B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	28.05B		AA
ILLUMINA, INC.	20.18B		BBB
OLYMPUS CORPORATION	10.96B		BB
REVVITY, INC.	10.4B		AA
BRUKER CORPORATION	6.26B		A			-
XTALPI HOLDINGS LIMITED	5.48B	-	A	-		-
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.	4.49B	-	-	-		-
TRANSMEDICS GROUP, INC.	3.91B		BB
HANGZHOU DIAGENS BIOTECHNOLOGY CO., LTD.	3.33B	-	-	-	-	-	-	-
Average	47.09B		A
Weighted average by Cap.			A